167 related articles for article (PubMed ID: 23349913)
1. Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.
Sato S; Kamada H; Watanabe T; Tsuji I; Fan J
PLoS One; 2013; 8(1):e54509. PubMed ID: 23349913
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding EGF-like growth factor: a juxtacrine growth factor.
Iwamoto R; Mekada E
Cytokine Growth Factor Rev; 2000 Dec; 11(4):335-44. PubMed ID: 10959080
[TBL] [Abstract][Full Text] [Related]
3. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
4. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
Higashiyama S; Iwamoto R; Goishi K; Raab G; Taniguchi N; Klagsbrun M; Mekada E
J Cell Biol; 1995 Mar; 128(5):929-38. PubMed ID: 7876316
[TBL] [Abstract][Full Text] [Related]
5. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
[TBL] [Abstract][Full Text] [Related]
6. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor.
Takemura T; Hino S; Kuwajima H; Yanagida H; Okada M; Nagata M; Sasaki S; Barasch J; Harris RC; Yoshioka K
J Am Soc Nephrol; 2001 May; 12(5):964-972. PubMed ID: 11316855
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
[TBL] [Abstract][Full Text] [Related]
8. A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF.
Sato S; Drake AW; Tsuji I; Fan J
PLoS One; 2012; 7(12):e51964. PubMed ID: 23251664
[TBL] [Abstract][Full Text] [Related]
9. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
Nakamura K; Mitamura T; Takahashi T; Kobayashi T; Mekada E
J Biol Chem; 2000 Jun; 275(24):18284-90. PubMed ID: 10749879
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.
Takemura T; Hino S; Murata Y; Yanagida H; Okada M; Yoshioka K; Harris RC
Kidney Int; 1999 Jan; 55(1):71-81. PubMed ID: 9893115
[TBL] [Abstract][Full Text] [Related]
11. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
Nakamura K; Iwamoto R; Mekada E
J Cell Biol; 1995 Jun; 129(6):1691-705. PubMed ID: 7790364
[TBL] [Abstract][Full Text] [Related]
12. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
Murayama Y; Miyagawa J; Shinomura Y; Kanayama S; Isozaki K; Yamamori K; Mizuno H; Ishiguro S; Kiyohara T; Miyazaki Y; Taniguchi N; Higashiyama S; Matsuzawa Y
Int J Cancer; 2002 Apr; 98(4):505-13. PubMed ID: 11920609
[TBL] [Abstract][Full Text] [Related]
13. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
Nishida M; Miyagawa J; Yamashita S; Higashiyama S; Nakata A; Ouchi N; Tamura R; Yamamori K; Kihara S; Taniguchi N; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1236-43. PubMed ID: 10807738
[TBL] [Abstract][Full Text] [Related]
14. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.
Adam RM; Danciu T; McLellan DL; Borer JG; Lin J; Zurakowski D; Weinstein MH; Rajjayabun PH; Mellon JK; Freeman MR
Cancer Res; 2003 Jan; 63(2):484-90. PubMed ID: 12543806
[TBL] [Abstract][Full Text] [Related]
15. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
16. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
17. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells.
Singh AB; Tsukada T; Zent R; Harris RC
J Cell Sci; 2004 Mar; 117(Pt 8):1365-79. PubMed ID: 14996914
[TBL] [Abstract][Full Text] [Related]
18. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching.
Takemura T; Hino S; Okada M; Murata Y; Yanagida H; Ikeda M; Yoshioka K; Harris RC
Kidney Int; 2002 Jun; 61(6):1968-79. PubMed ID: 12028437
[TBL] [Abstract][Full Text] [Related]
19. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation.
Lin J; Hutchinson L; Gaston SM; Raab G; Freeman MR
J Biol Chem; 2001 Aug; 276(32):30127-32. PubMed ID: 11340068
[TBL] [Abstract][Full Text] [Related]
20. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor.
Nanba D; Higashiyama S
Cytokine Growth Factor Rev; 2004 Feb; 15(1):13-9. PubMed ID: 14746810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
